Disabled people with lifelong and progressive conditions are being routinely called back for Personal Independence Payment reassessments that serve no functional purpose, according to Z2K's May 2026 analysis, published on 20 June 2026 — even as the government has moved, in parallel, to legislate exemptions for the most severely affected claimants.

The tension sits at the heart of the UK's current welfare reform cycle. On one hand, the government has announced that more than 200,000 people with the most severe, lifelong conditions will be protected from future Universal Credit reassessment, a commitment confirmed in June 2025 welfare reform disclosures and reinforced in further detail published ahead of the Bill's second reading. On the other, the existing PIP assessment framework continues to cycle claimants with conditions that will never improve back through a process designed, structurally, as if improvement were always plausible.

The Assessment Architecture Problem

PIP was designed with periodic reassessment built in — a reasonable default for a working-age benefit where functional capacity can change. The problem is that the system applies that default broadly, without systematic differentiation for conditions where deterioration, not recovery, is the clinical trajectory. Motor neurone disease, multiple sclerosis in its progressive forms, and a range of congenital conditions don't fit the reassessment logic. Yet claimants living with them are assessed on the same cycle as those whose needs may genuinely fluctuate.

Z2K's earlier report, 'Ending the Culture of Fear: Reforming the PIP Assessment', documented the broader dysfunction in the assessment process — the anxiety, the evidential burden placed on claimants, the gap between medical reality and assessment outcomes. The May 2026 analysis builds on that foundation by making the case specifically for a condition-based route: a pathway that would exempt certain claimants from reassessment based on their diagnosis and clinical prognosis rather than on an administrative schedule.

The government's own trajectory points in the same direction, if slowly. The Universal Credit, PIP and ESA Amendment Regulations 2026, laid in April 2026, introduced a temporary period of evidential protection for claimants with lifelong or deteriorating conditions — a stopgap that acknowledges the problem without fully resolving it. The Pathways to Work Green Paper committed to smoothing the assessment process for people with severe and lifelong conditions that will never improve, though the operative word is "committed": the commitment precedes delivery.

Why the Gap Persists

Z2K's response to the 2021 Health and Disability Green Paper raised the same concern — that repeat assessments for conditions unlikely to change significantly impose costs on claimants and the system alike without generating useful information. The fact that this argument is still being made in 2026, five years on, is itself diagnostic of how slowly structural change moves through the benefit system.

Part of the delay is definitional. Deciding which conditions qualify for permanent or long-term exemption requires clinical input, legal precision, and DWP operational capacity to implement — none of which moves fast. There is also a fiscal dimension: any categorical exemption reduces DWP's ability to conduct periodic eligibility reviews, which ministers have historically defended as a check against incorrect long-term awards. The political economy of welfare reform means that protection for the most severely disabled has to be negotiated alongside broader cost-containment objectives.

The 200,000-figure announced by the government last year is not trivial. But it covers Universal Credit entitlement specifically. PIP — the benefit that funds disability-related extra costs, paid separately from income replacement — operates under its own assessment regime, and the condition-based exemption Z2K is advocating targets that regime directly.

The practical stakes for individuals are considerable. Each reassessment requires claimants to re-evidence needs that, in clinical terms, haven't changed. Failed reassessments, or awards reduced on review, typically trigger tribunal appeals — a process that has seen success rates for appellants run well above 50% in recent years, a figure that points to systemic miscalibration rather than individual error.

Whether the Pathways to Work reforms, as legislated, will close the gap between the government's stated intent and what Z2K's data describes as daily operational reality remains the live question. The regulatory and legislative architecture is shifting. The question is whether it shifts fast enough, and with enough precision, to match the exemption to the condition rather than to an administrative category that still lags clinical reality.